These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 22034064)
21. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L Encephale; 2001; 27(1):53-9. PubMed ID: 11294039 [TBL] [Abstract][Full Text] [Related]
22. Antipsychotic drugs suppress the AKT/NF-κB pathway and regulate the differentiation of T-cell subsets. Chen ML; Tsai TC; Lin YY; Tsai YM; Wang LK; Lee MC; Tsai FM Immunol Lett; 2011 Oct; 140(1-2):81-91. PubMed ID: 21763349 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Duncan GE; Leipzig JN; Mailman RB; Lieberman JA Brain Res; 1998 Nov; 812(1-2):65-75. PubMed ID: 9813244 [TBL] [Abstract][Full Text] [Related]
25. Risperidone versus other atypical antipsychotic medication for schizophrenia. Gilbody SM; Bagnall AM; Duggan L; Tuunainen A Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551 [TBL] [Abstract][Full Text] [Related]
26. Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC. Baviera M; Invernizzi RW; Carli M Psychopharmacology (Berl); 2008 Feb; 196(2):269-80. PubMed ID: 17940750 [TBL] [Abstract][Full Text] [Related]
27. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Pillai A; Parikh V; Terry AV; Mahadik SP J Psychiatr Res; 2007 Aug; 41(5):372-86. PubMed ID: 16564057 [TBL] [Abstract][Full Text] [Related]
28. Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes. Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M Br J Pharmacol; 2012 Mar; 165(5):1543-55. PubMed ID: 21880034 [TBL] [Abstract][Full Text] [Related]
29. Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo. Bressan RA; Erlandsson K; Stone JM; Mulligan RS; Krystal JH; Ell PJ; Pilowsky LS Biol Psychiatry; 2005 Jul; 58(1):41-6. PubMed ID: 15992521 [TBL] [Abstract][Full Text] [Related]
30. Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate. Jardemark KE; Liang X; Arvanov V; Wang RY Neuroscience; 2000; 100(1):1-9. PubMed ID: 10996453 [TBL] [Abstract][Full Text] [Related]
31. Clozapine versus typical neuroleptic medication for schizophrenia. Wahlbeck K; Cheine M; Essali MA Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289 [TBL] [Abstract][Full Text] [Related]
32. Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity. Ahnaou A; Huysmans H; Van de Casteele T; Drinkenburg WHIM Transl Psychiatry; 2017 Dec; 7(12):1285. PubMed ID: 29249806 [TBL] [Abstract][Full Text] [Related]
33. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Duncan GE; Moy SS; Lieberman JA; Koller BH Psychopharmacology (Berl); 2006 Jan; 184(2):190-200. PubMed ID: 16362405 [TBL] [Abstract][Full Text] [Related]
34. Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study. Gemperle AY; Enz A; Pozza MF; Lüthi A; Olpe HR Neuroscience; 2003; 117(3):681-95. PubMed ID: 12617972 [TBL] [Abstract][Full Text] [Related]
35. Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies. Porter JH; Prus AJ Psychopharmacology (Berl); 2009 Apr; 203(2):279-94. PubMed ID: 18795269 [TBL] [Abstract][Full Text] [Related]
36. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality. Heresco-Levy U Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1113-23. PubMed ID: 14642971 [TBL] [Abstract][Full Text] [Related]
37. Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs. Gellman RL; Aghajanian GK Neuroscience; 1994 Feb; 58(3):515-25. PubMed ID: 7513386 [TBL] [Abstract][Full Text] [Related]
38. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Duncan GE; Moy SS; Lieberman JA; Koller BH Pharmacol Biochem Behav; 2006 Nov; 85(3):481-91. PubMed ID: 17097724 [TBL] [Abstract][Full Text] [Related]
39. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652 [TBL] [Abstract][Full Text] [Related]
40. Clozapine potentiation of N-methyl-D-aspartate receptor currents in the nucleus accumbens: role of NR2B and protein kinase A/Src kinases. Wittmann M; Marino MJ; Henze DA; Seabrook GR; Conn PJ J Pharmacol Exp Ther; 2005 May; 313(2):594-603. PubMed ID: 15659539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]